Guangdong, China

Huabin Liu

This inventor holds 1 USPTO granted patent. Top assignee: Artivila (Shenzhen) Innovation Center, Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huabin Liu. Retrieved from https://idiyas.com/inventor/huabin-liu-l2vbwo9a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huabin Liu - Innovator in Pharmaceutical Compounds

Introduction

Huabin Liu is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazole compounds. His research focuses on developing compounds that can be utilized in treating various diseases.

Latest Patents

Huabin Liu holds a patent for "Pyrazole compounds, pharmaceutical compositions thereof and use thereof." This patent discloses pyrazole compounds represented by a specific formula, along with pharmaceutical compositions containing these compounds. The compounds are particularly useful for inhibiting IRAK family kinases, which play a role in autoimmune diseases, inflammatory diseases, and cancers.

Career Highlights

Liu is currently associated with Artivila (Shenzhen) Innovation Center, Ltd., where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact the treatment of various health conditions significantly.

Collaborations

Some of his coworkers include Chubiao Xue and Liye Huang, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Huabin Liu's innovative work in the development of pyrazole compounds showcases his commitment to advancing pharmaceutical science. His contributions are poised to make a meaningful impact on the treatment of diseases linked to IRAK family kinases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…